We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYD icon
3351
China Yuchai International
CYD
$1.69B
$75K ﹤0.01%
4,145
-20,315
-83% -$315K
PDEX icon
3352
Pro-Dex
PDEX
$215M
$75K ﹤0.01%
2,623
+2,599
+10,829% +$60.3K
SB icon
3353
Safe Bulkers
SB
$789M
$75K ﹤0.01%
72,576
+55,090
+315% +$63.8K
UMBF icon
3354
UMB Financial
UMBF
$11.5B
$75K ﹤0.01%
1,539
-8,326
-84% -$420K
VNRX icon
3355
VolitionRx Ltd
VNRX
$6.87M
$75K ﹤0.01%
1,173
+1,115
+1,922% +$75.8K
PAMT
3356
PAMT Corp
PAMT
$277M
$75K ﹤0.01%
8,028
+6,020
+300% +$51.7K
ATXI
3357
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$75K ﹤0.01%
6
+2
+50% +$24.3K
SHLX
3358
DELISTED
Shell Midstream Partners, L.P.
SHLX
$75K ﹤0.01%
7,969
+6,534
+455% +$71.5K
AAXJ icon
3359
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.84B
$74K ﹤0.01%
+965
New +$73.5K
HEFA icon
3360
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.78B
$74K ﹤0.01%
2,677
+2,212
+476% +$61.3K
IXC icon
3361
iShares Global Energy ETF
IXC
$2.77B
$74K ﹤0.01%
+4,488
New +$84.8K
IMDX
3362
Insight Molecular Diagnostics
IMDX
$135M
$74K ﹤0.01%
2,675
+2,245
+522% +$64.4K
RCKT icon
3363
Rocket Pharmaceuticals
RCKT
$363M
$74K ﹤0.01%
3,208
-5,650
-64% -$139K
RNAM
3364
DELISTED
Avidity Biosciences
RNAM
$74K ﹤0.01%
+2,628
New +$76K
VITL icon
3365
Vital Farms
VITL
$471M
$74K ﹤0.01%
+1,826
New +$69K
ARQ icon
3366
Arq
ARQ
$101M
$74K ﹤0.01%
18,206
+14,122
+346% +$60.3K
AIU
3367
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
$74K ﹤0.01%
131
-50
-28% -$26.1K
CFO icon
3368
VictoryShares US 500 Enhanced Volatility Wtd ETF
CFO
$430M
$73K ﹤0.01%
1,341
-18,987
-93% -$1.02M
FCNCA icon
3369
First Citizens BancShares
FCNCA
$25.9B
$73K ﹤0.01%
229
+172
+302% +$66.4K
IEF icon
3370
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
$73K ﹤0.01%
+600
New +$73.2K
MRVL icon
3371
Marvell Technology
MRVL
$196B
$73K ﹤0.01%
1,850
+1,619
+701% +$59.6K
TCBI icon
3372
Texas Capital Bancshares
TCBI
$4.4B
$73K ﹤0.01%
2,365
-7,132
-75% -$225K
TYME
3373
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$73K ﹤0.01%
74,089
+50,982
+221% +$59.1K
GBIO
3374
DELISTED
Generation Bio
GBIO
$72K ﹤0.01%
+235
New +$56.2K
SNFCA icon
3375
Security National Financial
SNFCA
$243M
$72K ﹤0.01%
15,110
+3,357
+29% +$15.7K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.